NeuroOne Medical Technologies
NMTC
19 hedge funds and large institutions have $2.33M invested in NeuroOne Medical Technologies in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
107% more capital invested
Capital invested by funds: $1.13M → $2.33M (+$1.21M)
36% more funds holding
Funds holding: 14 → 19 (+5)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.93% more ownership
Funds ownership: 0.89% → 1.82% (+0.93%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.4M |
| 2 |
Walleye Capital
New York
|
+$252K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$167K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.3K |
| 2 |
SG Americas Securities
New York
|
-$3.75K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$864 |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$7 |
NMTC Hedge Fund Activity: Q3 2023 in Review
19 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2023, worth a combined $2.33M — up 107% from $1.13M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NMTC positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $1.4M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $12.3K sold.
- 19 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2023, up from 14 in Q2 2023.
- Funds reported $2.33M of NeuroOne Medical Technologies stock for Q3 2023, up 107% quarter-over-quarter.
- 6 funds opened new NeuroOne Medical Technologies positions in Q3 2023 and 1 closed out, a net change of +5 holders.
- The largest NeuroOne Medical Technologies buyer in Q3 2023 was Nantahala Capital Management, an estimated $1.4M added.
- The largest NeuroOne Medical Technologies seller in Q3 2023 was Tower Research Capital (TRC), an estimated $12.3K sold.
Based on aggregated 13F filings for Q3 2023.